Dechra Pharmaceuticals PLC — Major Shareholding Notification 2023

Jun 22, 2023

National Storage Mechanism | Additional information

RNS Number : 6455D

Dechra Pharmaceuticals PLC

22 June 2023

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0009633180

Issuer Name

DECHRA PHARMACEUTICALS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

JPMorgan Chase & Co.

City of registered office (if applicable)

Country of registered office (if applicable)

US

4. Details of the shareholder

Name	City of registered office	Country of registered office
J.P. Morgan Securities plc

5. Date on which the threshold was crossed or reached

20-Jun-2023

6. Date on which Issuer notified

22-Jun-2023

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	4.113289	3.256434	7.369723	8393365
Position of previous notification (if applicable)	5.078248	2.780273	7.858521

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB0009633180		4684550		4.113289
Sub Total 8.A	4684550		4.113289%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Cash-settled Equity Swap	31/07/2023	31/07/2023	Cash	198709	0.174455
Cash-settled Equity Swap	27/09/2023	27/09/2023	Cash	1257275	1.103955
Cash-settled Equity Swap	03/10/2023	03/10/2023	Cash	17	0.000014
Cash-settled Equity Swap	11/10/2023	11/10/2023	Cash	1259141	1.105592
Cash-settled Equity Swap	24/11/2023	24/11/2023	Cash	531428	0.466622
Cash-settled Equity Swap	28/11/2023	28/11/2023	Cash	224812	0.197397
Cash-settled Equity Swap	16/01/2024	16/01/2024	Cash	7841	0.006884
Cash-settled Equity Swap	20/02/2024	20/02/2024	Cash	6220	0.005452
Cash-settled Equity Swap	04/03/2024	04/03/2024	Cash	5090	0.004469
Cash-settled Equity Swap	03/04/2024	03/04/2024	Cash	38816	0.034069
Cash-settled Equity Swap	02/05/2024	02/05/2024	Cash	130	0.000114
Cash-settled Equity Swap	17/05/2024	17/05/2024	Cash	26	0.000022
Cash-settled Equity Swap	04/06/2024	04/06/2024	Cash	3452	0.003029
Cash-settled Equity Swap	19/06/2024	19/06/2024	Cash	1238	0.001086
Cash-settled Equity Swap	27/06/2024	27/06/2024	Cash	2144	0.001876
Cash-settled Equity Swap	02/07/2024	02/07/2024	Cash	4032	0.003534
Cash-settled Equity Swap	04/07/2024	04/07/2024	Cash	108	0.000094
Cash-settled Equity Swap	23/07/2024	23/07/2024	Cash	983	0.000862
Cash-settled Equity Swap	02/08/2024	02/08/2024	Cash	59002	0.051787
Cash-settled Equity Swap	23/12/2024	23/12/2024	Cash	227	0.000198
Cash-settled Equity Swap	11/07/2025	11/07/2025	Cash	3604	0.003163
Cash-settled Equity Swap	14/07/2025	14/07/2025	Cash	10982	0.009642
Cash-settled Equity Swap	16/01/2026	16/01/2026	Cash	3569	0.003133
Cash-settled Equity Swap	28/04/2026	28/04/2026	Cash	51774	0.045451
Cash-settled Equity Swap	18/06/2027	18/06/2027	Cash	19581	0.017193
Cash-settled Equity Swap	01/03/2028	01/03/2028	Cash	1	0.000000
Cash-settled Equity Swap	05/05/2028	05/05/2028	Cash	7520	0.006602
Cash-settled Equity Swap	30/05/2028	30/05/2028	Cash	1825	0.001602
Cash-settled Equity Swap	20/06/2024	20/06/2024	Cash	9268	0.008137
Sub Total 8.B2				3708815	3.256434%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
JPMorgan Chase & Co.	J.P. Morgan Securities plc	4.087681		7.344115%
JPMorgan Chase & Co.	J.P. Morgan Securities LLC
JPMorgan Chase & Co.	J.P. Morgan SE

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

Chain of controlled undertakings:

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

J.P. Morgan International Finance Limited (100%)

J.P. Morgan Capital Holdings Limited (100%)

J.P. Morgan Securities plc (100%)

JPMorgan Chase & Co.

JPMorgan Chase Holdings LLC (100%)

J.P. Morgan Broker-Dealer Holdings Inc. (100%)

J.P. Morgan Securities LLC (100%)

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

J.P. Morgan International Finance Limited (100%)

J.P. Morgan SE (100%)

12. Date of Completion

22-Jun-2023

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLUUOVRORUNUAR